Target intelligence / Profile preview

Chikungunya virus non-structural protein 2 (nsP2)

Target
nsP2
Molecular classification
Enzyme, Protease, Helicase, NTPase, RNA triphosphatase
01

Overview

Chikungunya virus non-structural protein 2 (nsP2) is a multifunctional enzyme essential for the replication and pathogenesis of the Chikungunya virus (CHIKV). It possesses several distinct enzymatic activities, including a C-terminal papain-like cysteine protease responsible for cleaving the viral polyprotein precursor into functional units, and an N-terminal region containing RNA helicase, NTPase, and RNA triphosphatase domains. Beyond its role in viral RNA synthesis, nsP2 is a key factor in evading the host immune response by inhibiting JAK-STAT signaling and inducing the shutoff of host cell transcription and translation. Due to its critical role in the viral life cycle, nsP2 is considered a primary target for the development of antiviral therapeutics, with research focusing on small-molecule inhibitors of its protease and helicase activities. While no drugs are currently FDA-approved specifically for this target, several experimental compounds and peptides have demonstrated potent inhibitory effects in preclinical models.

Other names
nsP2CHIKV nsP2Non-structural protein nsP2Alphavirus non-structural protein 2
02

Mechanism of action

Inhibition of the papain-like cysteine protease domain or the RNA helicase domain to prevent viral polyprotein processing and RNA replication.

03

Biological functions

Viral replicationPolyprotein processingHost immune evasionInhibition of JAK-STAT signalingHost transcription shutoff
04

Disease associations

InfectionChikungunya fever
05

Safety considerations

Potential for off-target effects on host cysteine proteasesRapid emergence of viral resistance mutationsTherapeutic window challenges due to host cell shutoff mechanisms
06

Interacting drugs

Semapimod

3 more in the full profile.

07

Biomarkers

Viral loadCHIKV RNA levelsSTAT1 phosphorylation levels

Beyond the preview

Go deeper on Chikungunya virus non-structural protein 2 (nsP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chikungunya virus non-structural protein 2 (nsP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call